These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
622 related articles for article (PubMed ID: 24906197)
21. Conditioned fear in low- and high-anxious rats is differentially regulated by cortical subcortical and midbrain 5-HT(1A) receptors. Ferreira R; Nobre MJ Neuroscience; 2014 May; 268():159-68. PubMed ID: 24657773 [TBL] [Abstract][Full Text] [Related]
22. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. Dos Santos L; de Andrade TG; Zangrossi Junior H Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111 [TBL] [Abstract][Full Text] [Related]
23. Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease rat model. Zhang QJ; Du CX; Tan HH; Zhang L; Li LB; Zhang J; Niu XL; Liu J Neuroscience; 2015 Dec; 311():45-55. PubMed ID: 26470809 [TBL] [Abstract][Full Text] [Related]
24. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats. Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026 [TBL] [Abstract][Full Text] [Related]
25. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment. Vicente MA; Zangrossi H Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045 [TBL] [Abstract][Full Text] [Related]
26. Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT Fedotova J; Hritcu L Gen Comp Endocrinol; 2017 Dec; 254():14-21. PubMed ID: 28919453 [TBL] [Abstract][Full Text] [Related]
27. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Gogos A; Kusljic S; van den Buuse M Pharmacol Biochem Behav; 2005 Jul; 81(3):664-72. PubMed ID: 15955549 [TBL] [Abstract][Full Text] [Related]
28. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Fogaça MV; Reis FM; Campos AC; Guimarães FS Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837 [TBL] [Abstract][Full Text] [Related]
30. Activation of postsynaptic 5-HT1A receptors improve stress adaptation. Zhou J; Cao X; Mar AC; Ding YQ; Wang X; Li Q; Li L Psychopharmacology (Berl); 2014 May; 231(10):2067-75. PubMed ID: 24258351 [TBL] [Abstract][Full Text] [Related]
31. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease. Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776 [TBL] [Abstract][Full Text] [Related]
33. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI. Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824 [TBL] [Abstract][Full Text] [Related]
34. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Winstanley CA; Theobald DE; Dalley JW; Robbins TW Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093 [TBL] [Abstract][Full Text] [Related]
35. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia. Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393 [TBL] [Abstract][Full Text] [Related]
36. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774 [TBL] [Abstract][Full Text] [Related]
37. Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain. Mueggler T; Razoux F; Russig H; Buehler A; Franklin TB; Baltes C; Mansuy IM; Rudin M Eur Neuropsychopharmacol; 2011 Apr; 21(4):344-53. PubMed ID: 20656461 [TBL] [Abstract][Full Text] [Related]
38. 5-HT1A receptors of the lateral septum regulate inhibitory avoidance but not escape behavior in rats. Viana Mde B; Zangrossi H; Onusic GM Pharmacol Biochem Behav; 2008 May; 89(3):360-6. PubMed ID: 18282594 [TBL] [Abstract][Full Text] [Related]
39. Decreased response of interneurons in the medial prefrontal cortex to 5-HT₁A receptor activation in the rat 6-hydroxydopamine Parkinson model. Zhang Q; Wang S; Zhang L; Zhang H; Qiao H; Niu X; Liu J Neurol Sci; 2014 Aug; 35(8):1181-7. PubMed ID: 24563117 [TBL] [Abstract][Full Text] [Related]
40. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Gomes KS; Nunes-De-Souza RL Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]